Did an Alzheimer's drug give Sue and Ken Bell more time? MaybeLeqembi and Kisunla, new Alzheimer's drugs, can slow disease progression but do not restore memory or cognition.
FDA advisors strongly back new Alzheimer's drug, despite risks and limitationsFDA advisors recommend approval of Alzheimer's drug donanemab for slowing disease progression.